Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Medtechs Get A Touch More Certainty With Brexit Transition Agreement

Executive Summary

With the UK scheduled to leave the EU one year, the UK medtech and lifesciences industries were becoming increasingly concerned about the government's lack ofplanning and the risk of being left high and dry in the post-Brexit environment. But the UK has bought more time now that the EU agreed to a withdrawal transition phase until the end of 2020. There are potentially meaningful positives in the agreement for medtechs on either side of the English Channel.


Related Content

Brexit Points Of Order: Hard Brexit Plans Nearer As UK Remains Vague On Device-Sector Impact
Brexit Update: UK Medtech Industry Viewpoint, And One Notified Body's Strategy
MedTech Europe's Brexit Challenge: Don't Forget The Kid In The EU Divorce
Next ASEAN Device Committee Meeting Looms, But National Regs Top Priorities
Brexit: Where Things Stand For Medtech
UK Medtechs Stress Need To Get It Right On Brexit As Prime Minister Addresses EU





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts